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SUMMARY
Antigenic relationships among the matrix proteins of influenza A viruses were analysed using a competitive radioimmunoassay technique. There were at least two antigenic determinants on the M protein of A/PR/8/34 virus. One antigenic determinant was shared by several influenza A viruses of human, avian, swine or equine origin, while the second determinant was not necessarily shared by all influenza viruses since it was not detected on the M protein of A/chicken/ Germany/N/49 virus. In addition, the cross-reactive determinant(s) of the M protein of N virus was not equally represented in other influenza A virus subtypes.
The matrix protein (M) is one of the major structural internal polypeptides on influenza A virus (Compans et al., 1970; Haslam et al., 1970) . Precipitation by antibody in agar gels indicated an antigenic reactivity common to all human influenza A viruses and the M protein was designated as a type-specific antigen (Schild, 1972) . This common antigenic reactivity was also found on M proteins derived from influenza viruses isolated from other mammalian or avian species (Oxford & Schild, 1975) . In this report a sensitive radioimmunoassay has been designed to examine the possible occurrence of more than one group of antigenic determinants on the M protein of influenza A viruses.
In order to have a complete spectrum of M proteins, representative strains of influenza A viruses from three human subtypes were used together with virus strains occurring in swine, birds and horses. All viruses used were either derived from infected allantoic fluid or purified through a sucrose density-gradient (Skehel & Schild, 1971) . M protein was separated from Sarkosyl NL-97 (ICN Pharmaceuticals, New York, U.S.A.)-disrupted A/PR/8/34 (H1N1) and A/chicken/Germany/N/49 (H10N7) ('N' virus) by agarose gel electrophoresis as described elsewhere (Lecomte & Croteau, 1981) and labelled with 400 /zCi Na125I (New England Nuclear) by a modification of the iodine monochloride method (Montelaro & Bolognesi, 1979) . The labelled M proteins were 95 to 97 % precipitable in 5 % trichloroacetic acid and had a specific activity of 1 × 106 to 4 × 106 ct/min//tg. To determine the dilution of antisera to be used in the competitive radioimmunoassays, 100 /A of STE-BSA (0.01 M-tris-HC1 pH 7.6, 1 mM-EDTA, 0-15 NaC1, 1% bovine serum albumin, 0.1% Sarkosyl), 50 ILl of anti-M serum (prepared in rabbits) diluted in STE-BSA and 20/zl of labelled M protein containing approx. 10000 ct/min were mixed together. The rabbit immunoglobulins were precipitated with an excess of a swine antiserum against rabbit immunoglobulins (DAKO-immunoglobulins, Cedarlane, Ontario, Canada). The reaction mixture was then incubated for 18 h at 4 °C. Precipitates were collected by centrifugation at 4 °C and washed three times with cold saline. The competitive radioimmunoassay reaction mixture was the same except that the dilution of antiserum added was that which precipitated 40 to 50 % of the labelled M protein and the competitive inhibition of binding of 12~I-labelled M protein by unlabelled virus or unlabelled M protein was measured. Competing M proteins or competing viruses were added immediately before the appropriate dilution of antiserum. When purified viruses or viruses from aUantoic fluid were tested, they were disrupted with 1% Sarkosyl at 0022-1317/81/0000-4660 $02.00 © 1981 SGM Short communications 56 °C for 15 min to achieve complete release of the M protein and were diluted, so as to obtain a final 0.1% Sarkosyl concentration. Greater concentrations of Sarkosyl have a dissociating effect in the binding of anti-M sera with 125I-labelled M protein. Monospecific antiserum against the M protein of 'N' virus was prepared in rabbits with M protein extracted from 7.5% SDS-polyacrylamide gel (Lecomte et al., 1979) . Rabbit antiserum was also prepared against 'cores' of A/Swine/Cambridge/39 (HswlN 1) which had been purified in 20 to 40% (w/w) sucrose gradients (22000 rev/min for 1 h in the Spinco SW27 rotor) after prior removal of haemagglutinin and neuraminidase by incubation with bromelain enzyme (Brand & Skehel, 1972) . The purity of the 125I-labelled M proteins was assessed by SDSpolyacrylamide gel electrophoresis using the discontinuous buffer system of Laemmli (1970) . The specificity of the antisera was assessed by radioimmunoprecipitation of ~zSI-labelled whole purified viruses with anti-M antibodies to M protein derived from A/PR/8/34 or 'N' virus and SDS-polyacrylamide gel electrophoresis analysis of the precipitates. Both sera precipitated a single protein of mol. wt. 26 000 and a smaller polypeptide with an apparent mol. wt. of 15 000. This latter comprised 6 to 10% of the labelled M proteins and appears to be a cleavage product of the M protein (Oxford & Schild, 1976) . These anti-M sera had no reactivity in immuno-double-diffusion or single radial-immunodiffusion tests with other influenza virus structural antigens: haemagglutinin, neuraminidase or nucleoprotein.
The antigenic determinants on the M protein of 'N' virus were examined by the extent to which unlabelled M proteins of different viruses competed with 12SI-labelled homologous M protein in its reaction with anti-M antibodies. Approx. 40 ng of unlabelled M protein from 'N' virus gave 50% inhibition of binding and could completely inhibit the homologous reaction at 500 ng (Fig. I a) . When Sarkosyl-disrupted 'N' virus, rather than isolated M protein, was used as a competitive inhibitor, threefold increased protein concentration was required to achieve 50% inhibition; this result is in accordance with the amount of M protein (approx. 33%) present in 'N' virus (Lecomte & Croteau, 1981) . As expected, influenza B viruses, B/Lee/40 and B/Hong Kong/3/73 which possess an antigenically unrelated M protein, showed no competitive inhibition in the test (Fig. 1 a) . Less than 50% inhibition was obtained with 500 ng of the Sarkosyl detergent-disrupted human virus strains A/PR/8/34, A/FM/1/47, A/Singapore/I/57, the avian strain A/Tern/SA/61 and the swine virus A/Sw/15/31. This reduced competition could indicate either different cross-reactive antigenic determinants on the M protein or a different concentration of M protein in the different viruses or a reduced concentration of the M protein itself due to incomplete solubilization of the concentrated and purified viruses. To exclude this latter possibility, the same competing viruses, but from infected allantoic fluid, were analysed in this same homologous system with identical results (data not shown). To exclude the possibility of a reduced concentration of M protein in the different viruses, competition was investigated in a heterologous system (Fig.  1 b) . For this, the competing unlabelled, disrupted purified viruses were analysed with the same labelled M protein from 'N' virus but with antibodies to M protein of A/ Sw/Cambridge/39 virus in place of the antibodies to protein of 'N' virus. In this system, only the cross-reactive antigenic determinants of the M protein of 'N' virus would be bound. All disrupted purified viruses competed equally well and furthermore, as little as 10 to 50 ng were sufficient to achieve 50% inhibition, whereas in the homologous system 50% inhibition (Fig.  1 a) could not be obtained with as much as 500 ng of virus proteins. It thus appears, that the reduced competing efficiency of the A/PR/8/34 virus and other representative human and animal viruses in their binding to the anti-M antibodies to M protein of'N' virus, compared to the 'N' virus, was not due to a reduced concentration of M protein or to a reduced concentration of cross-reactive antigenic determinants, but rather to a different reactivity of specific M protein antigenic determinants of 'N' virus which are not equally shared by the human and animal strains tested. We recognize that a limited number of antisera have been utilized in the present study and that the use of other antisera with different specificities may delineate further antigenic determinants on the M protein. In preliminary experiments using monoclonal antibodies to M protein, similar differences in antigenic reactions of M protein of various influenza A viruses were observed (J. Lecomte, unpublished results) .
The sequence of nucleic acid coding for the M protein has recently been reported (Both & Air, 1979; Winter & Field, 1980) and it should be feasible in the near future to locate exactly the antigenic determinants of the M protein defined here in this study. 
